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Abstract
As a result of their unique electronic, optical, and mechanical properties, carbon nanotubes 
(CNTs) have been implemented in therapeutic and imaging applications. In an idealized situation, 
CNTs would be disposed of after they transport their theranostic payloads. Biodegradation 
represents an attractive pathway for the eliminating of CNT carriers post-delivery and may be 
integral in catalyzing the release of the cargo from the delivery vehicle. Accordingly, recent 
research efforts have focused on peroxidase-driven biodegradation of CNTs. In this review, we not 
only summarize recent efforts to biodegrade CNTs in the test tube, in vitro, and in vivo, but also 
attempt to explore the fundamental parameters underlying degradation. Encouraged by the in vivo 
results obtained to date, we envision a future, where carbon-based nano-containers, which are 
specifically designed to target organs/cells, deliver their cargo, and biodegrade via peroxidase-
driven mechanism, will represent an attractive therapeutic delivery option in nanomedicine.
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1. Introduction
Structurally, single-walled carbon nanotubes (SWCNT) can be envisioned as a single sheet 
of graphene rolled seamlessly into a cylinder; multiwalled carbon nanotubes (MWCNTs) are 
comprised of concentrically nestled SWCNTs of increasing diameter. Because their 
geometries are characterized by nanometer-sized diameters (i.e. from 0.4 to 3 nm and 2 to 
100 nm for SWCNTs and MWCNTs, respectively) and a length of several micrometers [1], 
carbon nanotubes (CNTs) possess a high aspect ratio. Moreover, CNTs are endowed with 
unique electronic [2], optical [3], and mechanical properties [4], which enable this sp2-
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hybridized allotrope of carbon to be employed for diverse applications such as electronics 
[5], sensors [6, 7], composite materials [8], energy conversion devices [9], and medicine [10, 
11]. This review article is related to their drug delivery application and will examine issues 
related to in vitro and in vivo biodegradation of CNTs catalyzed by peroxidases.
1.1. CNTs and Drug Delivery
A vast variety of nanoparticles (NPs) composed of metals, metal oxides, quantum dots 
(QDs), polymers, and carbon (e.g. carbon nanotubes and graphene) are receiving increasing 
interest over the recent years due to their potential in vivo therapeutic or imaging 
applications [12–14]. As a result of their high surface area and unique optical and electronic 
properties, CNTs have the potential of becoming a highly efficient delivery vehicle for drugs 
and biomolecules [14]. Because as-prepared CNTs are hydrophobic, to enhance their 
dispersibility in aqueous environments and thereby implement this carbon-based 
nanomaterial for biomedical applications [15], CNTs must be modified by either covalent or 
noncovalent means; this action will not only enhance biodispersibility but also 
biocompatibility of CNTs. Once rendered biodispersible and biocompatible, the high surface 
area of the CNTs presents an attractive platform for therapeutic delivery, where peptides, 
nucleic acids, proteins, and drugs could be (1) stored in the large inner-tubular volume; (2) 
π-π stacked to the walls; and/or (3) covalently conjugated to defect sites on the walls/edges 
of this carbon-based nanomaterial [16]. Moreover, CNTs are proficient at entering the nuclei 
of cells [17], which may render this nanomaterial integral for gene therapy applications. 
Interestingly, the near-infrared (NIR) biological transparency window, which occurs in the 
range of 800 to 1400 nm, falls within the region where SWCNTs strongly absorb and emit 
light (i.e. 800 to 1600 nm) [14]. As a result, SWCNTs have been employed for photothermal 
therapy, photoacoustic imaging, and Raman detection/imaging [14].
The primary hindrance to employing CNTs for biomedical applications entails potential 
toxicity issues that include oxidative stress and inflammatory pathways [18]. By controlling 
physicochemical properties such as length and degree of functionalization and 
pharmacological parameters such as dosing, the toxicological properties of CNTs can be 
mitigated [19]. Moreover, in vitro and in vivo studies have been implemented to acquire 
insight into the biological transformation and long-run fate of CNTs; these studies have 
demonstrated that there exist pathways to mitigate toxicity through the biodegradation of 
CNTs. These findings are applicable to CNT drug delivery vehicle, where biodegradation 
may either catalyze the release of the cargo conjugated to the CNT carrier or destroy the 
CNT delivery vehicle post-release thereby mitigating potential toxicity. Accordingly, this 
article will guide the reader through these recent in vitro and in vivo efforts to biodegrade 
CNTs.
2. In vitro Degradation of CNTs Outside Living Systems
Recent reports have demonstrated that the plant peroxidase, horseradish peroxidase (HRP) 
[20–25], and the animal peroxidases, myeloperoxidase (MPO) [25–28] and eosinophil 
peroxidase (EPO) [29], catalyze the degradation/biodegradation of carbon nanomaterials. In 
this section, we investigate in test tube examples of and provide plausible explanations of 
enzyme-catalyzed degradation of CNTs. This section will function as a tutorial for later 
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sections in which cellular and in vivo studies that demonstrated biodegradation of CNTs are 
explored.
2.1. HRP – The Model Peroxidase System for CNT Degradation
In an early study, we demonstrated that HRP catalyzed the degradation of carboxylated 
SWCNTs in the presence of H2O2 [20]. HRP, which has been employed in applications 
ranging from biotechnology to bioremediation [30], represents a classical secretory plant 
peroxidase that is derived from the horseradish plant (Armoracia rusticana) [31]. This 
monomeric enzyme consists of a noncovalently bound ferriprotoporphyrin IX prosthetic 
heme group [31] as its active site. When HRP is in its native, resting state, this group is in 
the ferric, Fe(III), form. The heme center is converted into an oxo-ferryl iron (Fe4+=O) and a 
porphyrin π cation radical referred to as Compound I via a protein-assisted mechanism upon 
reaction with hydrogen peroxide (H2O2), which is reduced back to the ferric resting state by 
the peroxidase cycle (Figure 1A) [30].
In a following mechanistic investigations, we demonstrated that only SWCNTs that contain 
oxygen moieties/defect sites underwent degradation; pristine SWCNTs were not observed to 
degrade over the same time period [21]. The introduction of defect site that consist of 
oxygen functionalities (e.g. carboxyl, carbonyl, and hydroxyl groups) by strong oxidizing 
agents, represents one common methodology employed to enhance the biocompatibility of 
CNTs [32, 33]. Carboxyl groups are attached to the graphitic backbone by one bond [34]; 
therefore, because it is necessary to cleave only a single bond, CNTs functionalized with 
these groups would therefore appeared most susceptible to enzymatic oxidation versus other 
functional groups. Moreover, the ability of HRP to preferentially react on carboxylated 
CNTs was supported by the different degradation behavior of carboxylated MWCNTs [22, 
23]. As the carboxylation process can only impart functional groups to the outer layers of 
MWCNTs, the more pristine inner layers failed to be completely degraded after the 
exfoliation of outer layers.
As previously mentioned, pristine CNTs were not observed to degrade over the period of 
analysis [25]. This may be attributed to two reasons. The first explanation is related to the 
overall dispersity of CNTs in an aqueous media; because pristine CNTs are intrinsically 
hydrophobic, there exists a strong tendency for nanotubes to aggregate into bundles, ropes, 
and networks as a result of van der Waals forces. To counteract these effects, CNTs have 
been modified by numerous covalent and noncovalent modifications to render this 
nanomaterial more dispersible in an aqueous environment [15]. To this end, CNTs have 
been functionalized employing several methodologies, including: (1) the creation of defect-
sites via strong oxidant chemistry, (2) covalent chemistry performed on sidewall, (3) 
attachment of pyrene derivatives via π-π interactions, and (4) noncovalent wrapping 
utilizing surfactants/amphiphiles, polymers, and biopolymers [35]. These techniques often 
yield a high-quality dispersion, which is composed mainly of individualized nanotubes with 
the remainder consisting of small bundles; Coleman and coworkers demonstrated that the 
quality of these dispersions scale with the ζ-potential of the dispersion [36]. As the ζ-
potential increases, the electrostatic repulsion of the functional groups imparted by the 
dispersing agent/via covalent modification is sufficient to overcome the attractive van der 
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Waals interactions of the CNTs [37]. While the direct role of bundling on degradation has 
not yet been examined, all studies that reported degradation were conducted on 
functionalized CNTs that demonstrate minimal bundling.
The second factor, which is also related to dispersibility, entails nanotube-enzyme 
interactions. When dispersed in an aqueous media, the negative charge of carboxyl groups 
on the covalently functionalized SWCNTs may facilitate degradation by encouraging the 
proper orientation/proximity of the peroxidase enzyme's heme active site to the SWCNT 
substrate, which has been demonstrated by molecular modeling studies. Due to electrostatic 
interactions, the negatively charged carboxylated CNTs would orient themselves toward a 
positively charged arginine residue, Arg178, which is positioned near HRP's heme site 
(Figure 1B) [21]. On the other hand, pristine SWCNTs were predicted to orient themselves 
towards the distal end of the enzyme away from the active heme site thereby failing to 
undergo degradation [21].
Even if the functionalized CNTs are well dispersed and properly oriented relative to the 
enzyme's active site, oxidation/degradation is not expected to proceed unless the standard 
potential of the reactive intermediates of HRP exceed the value for CNTs. For example, the 
reactive intermediates of HRP have a mean standard potential (E0) of +0.884 V (Table 1) 
[38] while SWCNTs have a work function (V) under vacuum of ~5 eV and a corresponding 
standard potential (E0) of +0.5 V [39, 40]. Therefore, the reactive intermediates of HRP 
possess more positive redox potentials and are stronger oxidants than SWCNTs [25]. 
Consequently, SWCNTs should theoretically be spontaneously oxidized through the 
donation of electrons from their valence band to these mediators.
HRP represents a promising model system for fundamental studies and may be relevant for 
environmental applications relating to carbon nanotube bioremediation. For applications 
relating to nanotoxicity and drug delivery, more physiologically relevant peroxidases were 
examined.
2.2. MPO and EPO – Peroxidases that Generate Hypohalous Acids
In collaboration with others, we have further expanded the in vitro degradation of CNTs to a 
series of peroxidases derived from animals including humans. A representative study 
demonstrated that human myeloperoxidase (hMPO) degraded carboxylated SWCNTs [26]. 
MPO consists of a homodimeric protein that is predominately expressed in granules of 
neutrophils (i.e. a type of leukocytes). In response to the phagocytosis of bacterium, MPO is 
released from these granules primarily into phagolysosomal compartment during which this 
peroxidase enzyme functions as a bactericide through the generation of both reactive 
intermediates (i.e. formed via the peroxidase cycle) and oxidants that are formed during the 
halogenation cycle (Figure 1A) [31, 41–43]. During the halogenation cycle, MPO 
demonstrates the ability to oxidize Cl−, Br−, and the pseudohalide, SCN− at high rates; 
during the process, these substrates donate two electrons to Compound I to generate the 
ferric form of the enzyme and, in turn, are converted to the corresponding 
(pseudo)hypohalous acids (HXO, such that X = Cl, Br, SCN) [44].
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After incubating carboxylated SWCNTs with hMPO in the presence of both H2O2 and Cl− 
for 24 h, the dispersion appeared almost clear in color (Figure 2A). Moreover, the SWCNTs 
underwent structural deformation including both a decrease in size as revealed by dynamic 
light scattering (DLS) (Figure 2B) and an increase in defects as evidenced by the increase in 
the D/G band ratio, which was determined by Raman spectroscopy (Figure 2C). Degradation 
of the SWCNTs was also confirmed by the suppression of the metallic (M1) and 
semiconducting (S2) transition bands that characterize the vis-NIR absorption spectra for 
SWCNTs (Figure 2D). The control experiment, which excluded Cl− and therefore relied 
only on the reactive intermediates formed during the peroxidase cycle, demonstrated 
markedly less SWCNT degradation thereby suggesting the important role of the strong 
oxidant, hypochlorous acid (HClO), in the degradation process; the in vitro study by 
Vlasova et al. confirmed this finding [27]. Presumably, the synergetic effects of 
hypochlorite and the reactive intermediates of MPO facilitated a much higher efficiency of 
CNT degradation for the MPO/H2O2/Cl− system versus the HRP/H2O2 system. Of 
importance, small oxidants like HClO has the ability to diffuse from active site and oxidize 
CNTs; the more bulky reactive intermediates, on the other hand, must be in close enough 
proximity of the CNT to promote degradation. Moreover, the enzyme-catalyzed oxidation of 
CNTs may be in competition with other substances that have lower redox potential (i.e. 
more reductive), as shown in our recent study, where the enzymatic degradation of 
SWCNTs was mitigated by antioxidants added to the system [45].
For MPO, amino acid residues, Glu242, Asp94 and Met243, are covalently bound to the 
ferriprotoporphyrin IX heme group [31], and molecular simulations suggested the existence 
of two potential interaction sites for CNT binding depending on their functionality [26]. For 
acid treated SWCNTs, the positively charged arginine residues (i.e. Arg 294, 307, and 507), 
which reside near the proximal end of the heme group, strongly interacted with the 
negatively charged carboxylated nanotubes; this area also contained the catalytically active 
tyrosine residues, Tyr293 and 313 (Figure 1C) [26]. Alternatively, pristine SWCNTs 
appeared to favor a second binding site, which exists at the distal end of the heme group 
away from the tyrosine residues [26].
EPO also facilitated the degradation of CNTs. EPO, which is expressed by eosinophils (i.e. a 
type of leukocytes), assists in the destruction of invading parasites. Because, in general, 
parasites are larger than bacteria, eosinophils attach to these species and exocytose their 
granule contents, which is composed of EPO at 40% by mass. Interestingly, EPO possesses 
a 70% amino acid homology with MPO but weighs roughly half of latter enzyme (i.e. 69.8 
kDa versus 144 kDa, respectively) [44], and inflammation of the human lung is 
characterized by the presence of EPO [29]. Like MPO, EPO contains a modified heme 
groups that are composed of ferriprotoporphyrin IX as its active site and therefore can 
generate reactive intermediates by the peroxidase cycle and hypohalous acids by the 
halogenation cycle [44]. It is important to note that because of the differences in the active-
site topology and binding sites between MPO and EPO, the redox potentials of the enzymes 
(Table 1) does not always correlate with the rate constants that the enzymes exhibit for a 
given (pseudo)halide [44]. For example, at neutral pH and given physiological 
concentrations of Cl−, Br−, and, SCN−, MPO primarily generates HClO and HSCNO 
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although it has the ability to oxidize Br−. HBrO and HOSCN and primarily produced by 
EPO despite this enzyme being a strong enough oxidant to convert Cl− to HClO, [44]. The 
reduction potentials for these (pseudo)hypohalous acids at pH 7 are denoted by Table 2 [44].
For the in vitro experiment, carboxylated SWCNTs were incubated with human EPO 
(hEPO) under physiological condition with constant addition of H2O2 and NaBr. During the 
96 h incubation, degradation of the SWCNTs was visually observed by a gradual color 
fading of the SWCNT suspension. A decrease in both the S2 characteristic band for 
SWCNTs in the NIR spectra and the Raman-derived D/G band ratio was observed, which 
suggested the degradation of SWCNTs under EPO oxidation, which was also confirmed by 
transmission electron microscopy (TEM). Therefore, the reactive intermediates and HBrO 
acid generated by EPO through the peroxidase and halogenation cycles, respectively, 
successfully resulted in the degradation of oxidized nanotubes. Significantly, when 
lactoperoxidase (LPO) was incubated with H2O2 and Br−, CNT degradation was observed 
confirming the strong oxidizing role of HBrO [27].
For EPO, two binding sites were identified both of which are stabilized by the electrostatic 
interactions between the positively charged arginine residues (i.e. Arg205, Arg207 and 
Arg209 for binding site 1 and Arg94 and Arg99 for binding site 2) and the negatively 
charged oxygen-containing functionalities on oxidized SWCNTs (Figure 1D) [29]. Of these 
two sites, binding site 1 was identified to be located on the same side as the catalytic site, 
appeared to be closer to the entrance of the catalytic site versus binding site 2, and 
overlapped with one of the bromide ion binding sites. Consequently, these cumulative 
results indicate that binding site 1 of EPO was the preferred location for biodegradation of 
oxidized SWCNTs [29].
3. In vitro Degradation of CNTs in Cells
3.1. Factors that Facilitate in vitro Degradation in Cellular Culture
Having had success with enzyme-catalyzed degradation of CNTs in the test tube, cellular 
studies were performed to elucidate the effect of innate degradative enzymes of the cell on 
CNTs. To this end, the in vitro degradation of CNTs in cell culture has been thus far 
investigated [26, 29]. The results demonstrated that significant degradation of CNTs was 
typically observed in granulocytes such as neutrophils and eosinophils, and the degradation 
was associated with active oxidases and peroxidases that are rich in the aforementioned cells 
together with reactive intermediates, which are considered to be key factors for CNT 
degradation by cells.
3.1.1. Oxidative Stress Induced by CNTs—It is commonly accepted that the 
cytotoxicity of nanoparticles such as CNTs is largely derived from oxidative stress resulting 
from their small size and large specific surface area [46–48]. Moreover, the oxidative stress 
also arises from increased levels of reactive oxygen species (ROS) that include superoxide 
radical anions and hydroxyl radicals. As a natural byproduct of cellular respiration process 
in mitochondria, the ROS are normally balanced by a series of anti-oxidant enzymes. 
However, the cellular homeostasis can be disrupted when the intracellular ROS levels are 
significantly levitated by environmental stress (e.g. exposure to nanoparticles), thereby 
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leading to oxidative stress. It is believed that nanoparticles can trigger the formation of ROS 
through two different pathways [49]. Some transition metal-based nanoparticles can catalyze 
decomposition of peroxides and form ROS directly such as the Fenton reaction triggered by 
iron catalytic nanoparticles from unpurified SWCNTs [50]; while in more general cases, the 
ROS are generated by phagocytic cells of the immune system (i.e. neutrophils, eosinophils, 
and macrophages) in response to the extrinsic nanoparticles. When phagocytes actively 
internalize nanoparticles, the massive ROS generation process is considered to be NADPH 
oxidase-dependent [49, 51], where upon activation, NADPH oxidase ensembles at the 
phagolysosomal membrane and transfers electrons to oxygen to form superoxide in a 
process known as “oxidative burst” [52]. In turn, superoxide anions will dismutate to H2O2 
[53], which is an initiator of the aforementioned peroxidase cycle of MPO in neutrophils and 
EPO in eosinophils. CNTs, in particular, because of their large surface activity, are highly 
likely to induce oxidative burst.
3.1.2. Role of Oxidative Stress to the in vitro Degradation of CNTs—It is 
commonly thought that oxidative stress triggers cell damage and death, and this 
phenomenon may be the cause of many diseases and cancers [54, 55]. However, the 
beneficial effects of oxidative stress are receiving more and more attention in recent years as 
studies revealed the important immune functions of ROS in “oxidative signaling,” which 
activates the inflammatory response in phagocytic cells, as well as in the attack and 
degradation of pathogens [49, 56]. The massive generation of strong ROS in response to 
pathogen engulfment has a large enough oxidative potential to break C-C and C-H bonds in 
bacteria and viruses thereby leading to their degradation. This oxidative clearance of 
pathogens also applies to degradation of carbonaceous nanomaterials including CNTs as 
they share similar sizes and elemental compositions with bacteria or viruses.
The in vitro degradation of CNTs is more likely to occur in the activated phagocytic cells 
with high oxidative stress. As demonstrated by in test tube results, innate peroxidases, such 
as MPO in neutrophils and EPO in eosinophils, play a pivotal role in oxidative degradation 
of CNTs. Under natural inflammatory response, neutrophils are attracted and activated by 
chemoattractants at the inflammatory sites, and MPO is released thus being able to act both 
intra-and extra-cellularly [57]. H2O2, which originated from NADPH oxidase, forms inside 
the phagosome, activates MPO, and leads to the production of reactive enzymatic 
intermediates and oxidants (e.g. hydroxyl radicals, HClO, etc.) [53], both of which are 
responsible for CNT degradation. As a result, the phagosomes of the phagocytes provide the 
exact environment facilitating the degradation of CNTs as simulated under test tube 
conditions. Both H2O2-generating enzyme (e.g. NADPH oxidase) and oxidative peroxidase 
are essential factors for the degradation of CNTs inside phagocytes under oxidative stress. 
The presence of halide ions also facilitates the degradation process by forming strong 
oxidative hypohalous acids. Finally, in the in vitro experiment, chemoattractants and 
degranulation promoting agent must be added to promote degradation. While 
chemoattractants activate the phagocytic cells, and degranulation promoting agent (e.g. 
cytochalasin B) trigger the release of peroxidase.
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3.1.3. Cellular Internalization of CNTs—The in vitro degradation of CNTs may occur 
either inside or outside of the cells depending on the distribution of the peroxidase upon 
cellular activation. If the peroxidase is localized mainly inside of the cells, then CNTs must 
be pre-opsonized for efficient internalization. Opsonization can be achieved by 
functionalization of CNTs with immunoglobulins, which specifically target receptors on 
phagocytes [58]. For example, in our previous study of CNT degradation in neutrophils [26], 
most of the MPO was translocated into the intracellular phagolysosomal space, where 
degradation ensued. Therefore, the nanotubes were targeted with IgG for enhanced cellular 
uptake. A significant increase in uptake and degradation of IgG-nanotubes by neutrophils 
occurred relative to non-functionalized nanotubes. Additionally, coating with specialized 
“eat-me” signals such as phosphatidylserine also makes CNTs recognizable by different 
professional phagocytes [59]. In contrast, in the study of CNT degradation by eosinophils 
[29], opsonization of CNTs was not required as the biodegradative peroxidase EPO is 
exocytosed upon cellular activation.
3.2. Examples of in vitro Degradation
Although a plethora of studies have investigated the cellular uptake of CNTs and their 
subsequent effects [60–62], only a few studies have addressed the potential cellular 
clearance of CNTs through biodegradation. Neves, et al. reported that the RNA-coated 
oxidized double-walled CNTs taken up by human prostate adenocarcinoma cells in vitro 
underwent possible defect-induced structural change due to increasing D to G band ratios 
from the Raman spectra [63]. However, the potential degradation mechanism and the 
eventual fate of CNTs were not discussed. In order to understand the CNT degradation 
process in actual living systems, we and others have investigated the in vitro degradation in 
both neutrophils and eosinophils conducted by MPO and EPO, respectively.
3.2.1. The in vitro Degradation of CNTs by Neutrophils—Human neutrophils, 
which are rich in MPO, are a type of professional phagocytes that are activated in response 
of inflammation and engulf pathogens. In an in vitro experiment [26], the neutrophils were 
first treated with fMLP and cytochalasin B to increase the activity of the cells and trigger the 
release of hMPO. Next, the short, oxidized SWCNTs were functionalized with IgG for their 
efficient internalization into neutrophils, and they were subsequently incubated with 
activated neutrophils. The activated neutrophils were shown to undergo an oxidative burst 
thus generating increased levels of superoxide and H2O2 (Figure 3A, B). Raman microscopy 
confirmed that IgG-nanotubes were completely degraded by neutrophils during a period of 
12 h; on the other hand, only 30% of the non-IgG-treated nanotubes were degraded (Figure 
3C, D). It was found that both active hMPO and NADPH oxidase were essential for CNT 
degradation by neutrophils. Moreover, the in vitro degradation of CNTs was found to be 
more profound in neutrophils than in macrophages, which contain much lower level of 
hMPO versus neutrophils. Recently, Vlasova et al. demonstrated that PEGylated SWCNTs 
activated isolated human neutrophils to produce HClO, and both oxidized and PEGylated 
SWCNTs were determined to activate neutrophils in whole blood samples [64]. Therefore, 
the mechanism of CNT degradation by neutrophils stems from hMPO associated oxidative 
stress triggered by activated cells.
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3.2.2. The in vitro Degradation of CNTs by Eosinophils—When in an inflammatory 
state, eosinophils are an additional type of professional phagocytes that generate oxidative 
species via EPO. In order to simulate the inflammatory conditions that are induced by CNT 
exposure, CNT degradation experiments were carried out in a cellular culture system with 
highly purified murine eosinophils that were obtained from mouse bone marrow progenitors 
[29]. Different from MPO, which is expressed inside neutrophils for killing bacterial cells, 
EPO is exocytosed from activated eosinophils and is mainly responsible for destroying 
parasites [44]. Degranulation and exocytosis of murine EPO (mEPO) were triggered by 
cytochalasin B and a platelet-activating factor (PAF). Upon 48 h incubation of carboxylated 
SWCNTs with activated mEPO, TEM images revealed that the bulk of SWCNT bundles 
were degraded leaving residual CNTs and carbonaceous materials (Figure 4A, B). The 
degradation was also confirmed by a decrease in both the S2 band for the NIR spectra and 
the G-band for the Raman spectra of SWCNTs (Figure 4C–E). It was noted that the 
degradation of CNTs by eosinophils occurs extracellularly in contrast of degradation by 
neutrophils, as the mEPO is exocytosed upon cellular activation and functions by forming 
reactive intermediates and HBrO as described in Section 2.2.
4. Biodistribution, Clearance, and Fate of CNTs in vivo
The biodistribution, clearance, and fate of CNTs in vivo are influenced by administration 
method, length, and functionalization of this nanomaterial. The term “clearance” mostly 
refers to the excretion of CNTs through lymphatic, biliary, or renal pathways [65, 66]; an 
alternative mechanism of CNT clearance via enzyme-catalyzed biodegradation in vivo is 
rarely discussed in the literature and will be the focus of Section 5. Importantly, the method 
by which CNTs are administered influences their biodistribution and clearance [67]. CNTs 
that are injected intravenously demonstrate low toxicity as a result of an opsonization 
regulated reticuloendothelial system (RES) capture, which minimizes the interaction of 
SWCNTs with parenchyma cells and restricts the toxicity to primarily the Kupffer cells 
(KC) and alveolar macrophages (AM) [68]. Therefore, CNT clearance mechanisms from 
AM and KC include either departing the lung via mucus through mucociliary transport [69] 
or being slowly excreted from KCs via bile [65]. On the other hand, intratracheally instilled 
SWCNTs and SWCNTs that were injected into the peritoneal cavity of mice induce more 
serious injury including inflammation and the formation of granuloma [70–72].
Depending on their length, CNTs may exhibit different pathogenic behaviors. Long fibers 
and large aggregates of CNTs, which are difficult for macrophages to phagocytose, typically 
induce asbestos-like pathogenicity including chronic inflammation and formation of 
granulomas and fibrosis in the lungs [72, 73]. After administration, these bulky materials 
often have a much longer retention time within the tissues and are not cleared. In contrast, 
short, functionalized CNTs tend to be more easily phagocytosed by the mononuclear 
phagocyte system or cleared through different pathways [66, 74, 75]. This was exemplified 
by the work of Kolosnjaj-Tabi et al. [76]. After administering SWCNTs of different lengths 
into Swiss mice via intraperitoneal injection, their data revealed that: large aggregates of 
SWCNTs (>10 μm) irremediably induce granuloma formation; smaller aggregates (<10 μm) 
were engulfed by phagocytes but remain persistent in cells for several months; and small, 
well-functionalized SWCNTs (<300 nm) were eliminated via the kidneys and bile ducts.
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The surface modification of a CNT has been reported to directly affect its inflammatory 
response and facilitate its clearance. To this end, numerous strategies are available to reduce 
the size of CNTs and tune their surface properties. For example, functionalization with 
DNA, protein, or polymers may improve the dispersion and biocompatibility of CNTs [77–
79]. Dai's group demonstrated that short SWCNTs (~100 ± 50 nm) functionalized with 
branched PEGylated phospholipids chains exhibited a significant increase in circulation time 
(≈15 h) versus non-branched PEGylated SWCNTs; they hypothesized that branched PEG 
structures on SWCNTs provided optimal biological inertness and resistance to opsonization/
nonspecific binding of proteins [65]. In turn, this limited the rapid RES uptake of the 
SWCNTs and thus prolonged their circulation time in the blood. After 1 day of circulation, 
SWCNTs were predominantly located in the RES organs of the liver and spleen with uptake 
inversely depended on the degree of SWCNT surface PEGlyation. Meanwhile, over a three 
month period, the concentration of SWCNTs remained very low in most of the organs 
except for the liver and spleen in which the concentration of SWCNTs steadily decreased 
over the 3-month period with retention in the spleen and liver inversely proportional to the 
degree of PEGlyation. Because excretion of SWCNTs via the renal pathway was restricted 
to nanotubes that were very short in length (i.e. <50 nm in length, diameter 1–2 nm, less 
then the renal excretion threshold), Dai and coworkers determined that the primary 
mechanism for the removal of SWCNTs involved the biliary pathway as evidenced by 
SWCNTs being found in both the intestine and feces.
In contrast to Dai's work [65], Singh et al. observed rapid, first-order clearance of 
functionalized/water dispersible 111In-labeled DTPA-SWCNTs that were between 300 and 
1,000 nm in length from the blood through the renal excretion pathway without any toxic 
side effects or mortality [80]. The difference between the observations of Dai and Singh may 
have stemmed from the fact that PEGylated nanotubes possess unique properties that effect 
pharmacokinetics, biodistribution, and clearance/fate. Recently, Sacchetti et al. completed a 
study, where they examined the effects of surface charge and PEG conformation on the 
adsorption of plasma proteins to SWCNTs and the resulting biodistribution [81]. Since the 
conformation of the PEG group affects the adsorption of the corona's major components, it 
was determined that the conformation of PEG had greater influence over the composition of 
the protein corona versus the surface charge imparted on a nanotube. This is important 
because the adsorption of certain proteins may directly influence the biodistribution of 
PEGylated SWCNTs.
5. In vivo Biodegradation of CNTs
5.1. Setting the State for Biodegradation: Inflammatory Response and Recruitment of 
Professional Phagocytes
Depending on their dimension, functionalization and administration methods, CNTs may 
introduce different levels of acute or chronic inflammation [61, 73, 82], causing fibrosis, 
oxidative stress, and mutagenesis [83]. CNT-induced inflammatory response is usually 
associated with increasing levels of cytokines and professional phagocytes such as 
macrophages and neutrophils [61]. For example, Muller et al. demonstrated that, compared 
with un-ground MWCNTs, MWCNTs ground with an oscillatory ball mill induced more 
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significant cytotoxicity and inflammatory response in lungs, accompanied with increased 
levels of neutrophils and eosinophils [84]. Therefore, the accumulation of professional 
phagocytes during inflammation is postulated to be responsible for this clearance by 
engulfment of CNTs [73] and/or creating oxidative environment that facilitates the 
biodegradation of CNTs in vivo [27]. This behavior was corroborated by Vlasova et al., who 
observed both an increase in the percentage of circulating neutrophils and activation of 
neutrophils and macrophages in the peritoneal cavity thereby suggesting an inflammatory 
response after an intraperitoneal injection of PEGylated SWCNTs into mice [64]. In turn, 
the activated neutrophils are capable of producing high, local concentrations of HOCl, 
which represent favorable conditions for biodegrading the nanotubes.
5.2. The in vivo Biodegradation of CNTs in the Lung
The in vivo degradation of CNTs was possibly observed in a study by Elgrabli et al. [85]. 
Oxidized MWCNTs were intratracheally instilled into rat lungs at different doses. The 
injected MWCNTs were found to be predominantly distributed in the lungs and gradually 
diminished from the lung during 180 days. A significant increase in the number of alveolar 
macrophages (AMs), which are responsible for engulfing MWCNTs, was observed. The 
phagocytosis of MWCNTs by AMs was directly dependent on dosage and inversely related 
to time. To this end, the number of AMs that contained MWCNTs increased with an 
increasing dosage of MWCNTs, and as time progressed, this value gradually decreased. It 
was postulated that the AM cells underwent apoptosis after phagocytosis of MWCNTs and 
were subsequently engulfed by other AMs. The interesting finding of this study was that 
MWCNTs underwent both physical and chemical modification 15 days after instillation. 
Significant diminution of MWCNT length was noticed suggesting the cleavage of 
MWCNTs by rat lungs, along with the introduction of different functional groups on 
MWCNTs (Figure 5). Although detailed characterization and mechanism of this structural 
change remained vague, the authors proposed that the AMs might modify the MWCNTs 
upon phagocytosis and facilitate their further elimination from the lung.
In a recent collaborative study, we investigated the in vivo degradation of oxidized SWCNTs 
instilled into the lung via pharyngeal aspiration of either wild-type (w/t) or myeloperoxidase 
knockout (MPO k/o) mice (i.e. mice with MPO deficiency) [28]. For both types of mice, a 
pulmonary inflammatory response and the accumulation of neutrophils was observed as 
early as 1 day after exposure. While the phagocytized SWCNTs remained persistent in the 
neutrophils of MPO k/o mice and induced a stronger fibrogenic response, SWCNTs 
underwent significant diminution in the lungs of w/t mice versus MPO k/o mice as 
evidenced through quantitative imaging (Figure 6). Twenty-eight days after exposure, TEM 
and Raman analysis also confirmed that the oxidized SWCNTs underwent biodegradation as 
evidenced by the shortening of the CNTs and an increase in the ratio of the D to G bands for 
the respective techniques; this effect, however, was more apparent in the w/t mice, which 
indicated the crucial role of MPO in oxidatively biodegrading SWCNTs in vivo [26]. Since 
the degradation was also observed in MPO k/o mice at a much lower rate, other 
hemeperoxidases (e.g. EPO and LPO) may also contribute to the in vivo biodegradation 
process. In agreement with our previous in vitro study, the in vivo results strengthened the 
importance of MPO containing neutrophils in the biodegradation of CNTs.
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5.3. The in vivo biodegradation of CNTs in the Brain
Nunes et al. recently investigated the fate of MWCNTs in mouse neuronal tissue [86]. 
Amine-functionalized MWCNTs were stereotactically injected into the motor cortex of a 
mouse brain, where microglia functioned as the primary professional phagocytes for the 
brain's immune system. TEM imaging was performed on parenchyma samples near the 
injection site 2 days post-injection. While widespread microglia internalization of MWCNTs 
was considered to be the predominant mechanism of early tissue response, the micrographs 
revealed that this nanomaterial was also internalized into different types of brain cells 
including neurons (Figure 7A). Aggregates of MWCNTs were localized in the possible 
phagolysosomal vesicles through active endocytosis or phagocytosis, and individualized 
MWCNTs were mainly internalized in the cytoplasm through a direct membrane 
translocation pathway. Besides the intact nanotubes, many internalized MWCNTs were 
observed to undergo severe structural deformation yielding amorphous debris (Figure 7B), 
which indicated the widespread initiation of the degradation process in microglia on day 2 
after injection. This structural deformation was confirmed by Raman spectra that were taken 
of the injected brain tissue on days 2 and 14 after injection (Figure 7C, D, E), which 
demonstrated an overall reduction in the intensity of the D and G peaks coupled with an 
increase in background noise thereby indicating diminishing CNT content. A decrease in the 
D to G band ratio was observed, however, which might indicate the incomplete degradation 
of MWCNTs in microglia as was observed in another degradation experiment conducted on 
MWCNTs [23]. While the authors attributed the possible in vivo degradation of MWCNTs 
to the highly efficient phagocytosis capacity of microglia cells that possess both an oxidative 
lysosomal environment with low pH and an abundance of hydrolytic enzymes, the actual 
mechanism of degradation remained hypothetical.
6. Comparison to Other Nanomaterials
Unlike peroxidase-catalyzed degradation of CNTs and graphene oxide [24], the 
biodegradation of other nanoparticles may undergo completely different pathways 
depending on their chemical properties. The most inert gold nanoparticles (NPs) are rarely 
reported to undergo biodegradation in cells [87] with their eventual in vivo fate likely to 
include retention inside organs such as the liver and spleen [88]. In contrast, iron oxide NPs 
can be gradually degraded in the acidic environment of endosomes or lysosomes after 
cellular uptake thereby releasing ferric ions [89]. Quantum dots (QDs) such as CdSe and 
CdTe were also reported to undergo a pH-dependent degradation [90], and the presence of 
intracellular hypochlorous acid and hydrogen peroxide may facilitate the degradation 
process [91]. The degradation of QDs is not desired because the released Cd2+ ions are 
highly cytotoxic, which, in turn, greatly limits the biomedical applications of QDs. Different 
types of inorganic NPs, which include semiconductor, metal, metal oxide, and lanthanide-
doped QDs are commonly encapsulated in polymers or coated with lipids or surfactants to 
preserve the as-synthesized properties of the nanomaterial [92]. The surface properties of 
these carbonaceous coatings, which are highly vulnerable to oxidative biodegradation, will 
impact the interactions of NPs with cells and components of biofluids thus defining their 
fate and effectiveness in the body. Therefore, peroxidase-catalyzed biodegradation reactions 
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can affect not only carbonaceous NPs but also many other types of NPs that utilize carbon-
based coatings as a part of their formulation.
A large group of biocompatible polymeric NPs has been developed as novel drug delivery 
vehicles such as poly(lactic acid) (PLA), poly(lactic-co-glycolic acid) (PLGA), etc., which 
can be degraded through either enzymatic or hydrolytic pathways [93, 94]. Along these 
lines, de Gracia Lux et al. developed polymeric capsules that contained aryl boronic ester 
protecting groups integrated into their polymer design [95]. Due to the cleavage of the 
boronic ester by biological levels of H2O2 (i.e. 50–100 μM), which resulted in the 
degradation of the polymer backbone, these nanoparticle demonstrated the ability to release 
cargo when incubated in physiological environments such as with activated neutrophils.
7. Outlook
Ideally, delivery vehicles (e.g. CNTs or graphene derivatives) that transport theranostic 
payloads should be disposed of after arriving at their target destination sites. To this end, 
while many chemical methodologies have been developed to “oxidatively cut” and degrade 
CNT, the aggressive nature of these oxidants precludes their possible employment in 
physiologically relevant environments (i.e. tissues and body biofluids). Consequently, this 
prompted an active search for possible enzymatic mechanisms and pathways whereby mild 
and controlled oxidation reactions would effectively biodegrade CNTs. The discovery of 
peroxidase-driven biodegradation processes is an important milestone on the path to 
regulated and targeted spatiotemporal degradation of CNT. Through either noncovalent 
functionalization or covalent attachment through stimuli-cleavable groups, specialized 
signaling molecules of lipid and/or protein nature will facilitate the internalization of CNTs. 
Also, one can envision the attachment of chemical/biological species that will activate the 
professional phagocytes. Acute and resolution phases of the body's inflammatory response 
are characterized by the predominant accumulation of myeloperoxidase (MPO)-rich PMNs 
and macrophages, respectively. One can envision that MPO-driven oxidative reaction will 
represent the dominant pathways for the CNTs biodegradation during the acute phase. In 
contrast, macrophages, which are relatively poor in MPO, may utilize a different oxidizing 
system such as peroxynitrite generators to be involved in the CNT biodegradation process. 
In this regard, NADPH-oxidase and NO synthases (e.g. iNOS) may be particularly important 
as sources of superoxide radicals and NO•, respectively. By producing these reactive oxygen 
and nitrogen species (i.e. ROS and RNS), macrophages are involved in the production of 
peroxynitrite, whose high oxidizing potential is sufficient to trigger CNT oxidative 
degradation. Therefore, by tailoring functionalization, one can envision a possible tool for 
regulating the biodegradation of CNTs coated with important payloads. Alternatively, nano-
containers with encapsulated freight can be utilized in ways where oxidative biodegradation 
of the vehicle will facilitate the release of the inner contents as they reach the desired targets. 
While different types of nano-containers have been designed and fabricated [96–98], 
approaches towards the utilization of peroxidase-catalyzed oxidative biodegradation on 
these types of delivery nano-devices in target organs/cells have not yet been developed and 
represent an exciting future area of research.
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(A) The catalytic peroxidase cycle for HRP, MPO and EPO. For MPO and EPO, compound 
I is reduced directly to the resting state via conversion of halide to hypohalite (red path). (B, 
C, D) Molecular modeling of carboxylated SWCNTs binding to the active sites of (B) HRP, 
(C) MPO and (D) EPO. Panel B reproduced from [21] Copyright American Chemical 
Society 2009, Panel C reproduced from [26] Copyright Macmillan Publishers, Ltd. 2010, 
and Panel D reproduced from [29] Copyright Wiley-VCH 2013.
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(A) Photographs of carboxylated single-walled carbon nanotubes (SWCNTs) incubated with 
or without degradative reagents after 24 h. (B) Dynamic light scattering data of different 
samples showing decreasing sizes of degraded nanotubes. (C) Raman spectra of SWCNTs 
before and after 24 h of degradation by MPO/H2O2/Cl−. (D) Visible-near infrared (Vis-NIR) 
absorption spectra of SWCNTs being degraded during 24 h. Adapted from [26] Copyright 
Macmillan Publishers, Ltd. 2010.
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(A, B) Quantitative assay of extracellular superoxide radicals (A) and H2O2 (B) generated 
by activated neutrophils. *Significant different from control (P<0.05); error bars represent 
standard deviations (s.d.).) (C, D) Raman spectra of neutrophils containing IgG-nanotubes 
after 2 h (C) and 8 h (D). Adapted from [26] Copyright Macmillan Publishers, Ltd. 2010.
Kotchey et al. Page 22














(A, B) TEM images of SWCNTs alone (A) and after 48 h of incubation with activated 
eosinophils (B). (C) The absorbance of S2 band at 1075 nm from SWCNTs alone and 
SWCNTs after 48 h of incubation with activated eosinophils. (D, E) Raman spectra of 
SWCNTs unincubated (D) and SWCNTs incubated with eosinophils (E) showing the 
diminishing D and G bands. Reproduced from [29] Copyright Wiley-VCH 2013.
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(A) Length distribution of MWCNTs from different samples performed on at least 100 
MWCNTs per sample. Control 1: MWCNTs along; Control 2: MWCNTs incubated for 15 
days with suspension of lysed cells from broncheoalveolar lavage (BAL); MWCNT: 
MWCNTs injected to rats after 15 days. *Significant from control (p<0.05); error bars 
represent s.d. (B) Infrared spectra of samples from (a) Control 1, (b) Control 2, and (c) 
MWCNTs injected to rats after 15 days. Possible peak assignment: 1. OH from H2O, 2. OH 
from alcohol group, 3. low quantity of carbonyl group, 4. nitrogen functional group. 
Reproduced from [85].
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(A, B) Quantitative imaging of the lung tissue sections from w/t mice treated with SWCNTs 
illustrated with green pseudo-color after 1 day (A) and 28 days (B). Inset in A - higher 
magnification of a field with the presence of SWCNT (green punctuate spots pointed by 
white arrows). (C) Ratio of the volume of SWCNTs to the total lung volume for w/t and 
MPO k/o mice 1 day and 28 days after injection, respectively. Adapted from [28].
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(A) Low resolution TEM image of microglia with amine-functionalized MWCNTs localized 
intracellularly, both intact individualized MWCNTs (dash box) and structurally deformed 
MWCNT debris (solid) is exhibited. (B) TEM image with higher resolution showing co-
existing intact MWCNTs (top), carbon sheets unraveled form MWCNTs (middle) and 
deformed MWCNT debris. (C, D, E) Raman spectra taken from the starting MWCNTs 
before injection and brain sections 2 days and 14 days after MWCNT injection. The 
corresponding D to G band ratios (ID/IG) are recorded. Reproduced from [86] Copyright 
Future Medicine 2012.
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Table 1
Standard Reduction Potentials (at pH 7) Along the Peroxidase Cycle for Peroxidase Involved in CNT 
Degradation/Biodegradation
Standard Reduction Potentials (V)
HRP [39] MPO [45] EPO [45]
Compound I/ Resting State -- 1.16 1.10
Compound I/Compound II 0.898 1.35 --
Compound II/ Resting State 0.869 0.970 --
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Table 2
Two-electron Reduction Potentials of (Pseudo)hypohalous Acids at pH 7 in Water [45]
Standard Reduction Potentials (V)
HClO/Cl− HBrO/Br− HSCNO/SCN−
1.28 1.13 0.56
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